Press release
Anticonvulsants Market to Witness Robust Expansion Throughout the Forecast Period 2016-2026
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used in treatment of bipolar disorder and in neuropathic pain management.Anyone could potentially have a single epileptic seizure at some point in their lives. This is not the same as having epilepsy, which is a tendency to have seizures that start in the brain. Epilepsy can affect people of any age group. Though brain injury, brain cancer, drug and alcohol misuse and stroke are some of the reasons for epileptic seizures, the exact reason for convulsions is not known. Some of the common symptoms which occur before convulsions include, visual loss, strange feeling, nausea, numbness in body parts, headache and racing thoughts.
Request to Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1337
Anticonvulsants Market: Drivers and Restraints
Increasing awareness about the anticonvulsants available in the market, patent expiration of many blockbuster drugs are some of the major factors that are driving the global anticonvulsants market towards growth. There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the US by FDA. Moreover, three trends involving consumption of AEDs have become clinically important and must be considered by all who treat patients with epilepsy. These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. While, high costs and unavailability of convenient dosage forms of both generic and branded anticonvulsants are restraining the growth of novel therapies in the anticonvulsants market.
Anticonvulsants Market: Segmentation
Anticonvulsants market is segmented based on product type, application, end user and geography.
Based on product type, the anticonvulsants market is segmented as follows:
Barbiturates
Aldehydes
Benzodiazepines
Aromatic allylic alcohols
Carboxamides
Bromides
Carbamates
Sulfonamides
Fructose derivatives
Pyrrolidines
Triazines
Fatty acids
Oxazolidinediones
Ureas
GABA analogs
Propionates
Hydantoins
Pyrimidinediones
Valproylamides (amide derivatives of valproate)
Others
Based on application, the anticonvulsants market is segmented as follows:
Epilepsy
Fibromyalgia
Migraine
Neuropathic pain
Bipolar disorder
Anxiety
Borderline personality disorder
Based on end user, the anticonvulsants market is segmented as follows:
Hospitals
Clinics
Ambulatory surgical clinics
Anticonvulsants Market: Overview
Seizures are expected to result in physical, psychological and social repercussions. People with epilepsy could adhere rigorously to their medication regimes in order to prevent these deleterious outcomes. Treatment of epileptic seizures has led to the growth of anticonvulsants market. Barbiturates were the first antiepileptic drugs. These are more effective and tolerable than bromides. Hydantoins are the first to be known as modern antiepileptic drugs. Succinimides are an old group of drug which are rarely prescribed nowadays. Consequently with these antiepileptic or antiseizure drugs, anticonvulsants market is growing immensely leaving a significant impact on the treatment of epileptic seizures. The antiepileptic drug market is threatened by generic completion, which has been increasing dramatically in the face of patent expirations among several of the major branded antiepileptics. However, there have been cases where generic antiepileptic drugs have not been as efficacious as their branded counterparts have.
Anticonvulsants Market: Region-wise Outlook
Region wise, the global anticonvulsants marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Currently, North America dominates the anticonvulsants market followed by Europe. Asia-Pacific is expected to emerge as a lucrative region, owing to factors such as increasing healthcare spending, improving healthcare infrastructure, and increasing demand for drugs. Given these factors, the market for anticonvulsants is likely to grow rapidly in Asia-Pacific region.
Request Report for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1337
Anticonvulsants Market: Key Players
Some of the key players, contributing to global anticonvulsants drug market, are Johnson & Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc, Pfizer Inc., Abbott Laboratories, Cephalon Inc. and Shire plc. Pfizer has been estimated to cover the largest market share in the antiepileptic market, accounting for close to one-third of total revenues of the market with it two leading brands.
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anticonvulsants Market to Witness Robust Expansion Throughout the Forecast Period 2016-2026 here
News-ID: 1445185 • Views: …
More Releases from Future Market Insights

Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
The Anesthesia Equipment Market is witnessing robust growth, with its value estimated at USD 9.3 billion in 2025 and projected to nearly double to USD 18.2 billion by 2035. This growth trajectory represents a compound annual growth rate of 7.0%, driven by increasing surgical volumes, rising prevalence of chronic respiratory and cardiovascular disorders, and ongoing expansion of healthcare infrastructure. The market is undergoing transformative change, as both established manufacturers and…

Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time…

Electric Power Sports Market to Reach USD 18.5 Billion by 2035
The global Electric Power Sports Market is on a fast track to transformation, as consumers, manufacturers, and policymakers align on one powerful goal: sustainable, high-performance recreational experiences. Valued at USD 10.3 billion in 2025, the market is projected to expand to USD 18.5 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.0%.
This momentum is set to generate an absolute dollar opportunity of USD 8.2 billion over…

Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovatio …
The global hair straightener market is entering a transformative growth phase, as industry leaders and emerging brands alike innovate to meet rising consumer demand for advanced hair styling solutions. Valued at USD 7.1 billion in 2025, the market is projected to reach USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period.
Between 2025 and 2030, the market is set to rise steadily…
More Releases for Anticonvulsants
Key Trends Reshaping the Anticonvulsants Market: Innovative Product Development …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Anticonvulsants Market Size Growth Forecast: What to Expect by 2025?
The growth of the anticonvulsants market has been consistent in the past years, rising from $18.85 billion in 2024 to $19.25 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 2.1%. This historical growth is the result…
Key Trends Reshaping the Anticonvulsants Market: Innovative Product Development …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Anticonvulsants Market Size Growth Forecast: What to Expect by 2025?
The growth of the anticonvulsants market has been consistent in the past years, rising from $18.85 billion in 2024 to $19.25 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 2.1%. This historical growth is the result…
The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market: Key Fac …
The Anticonvulsants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anticonvulsants Market Size During the Forecast Period?
The Anticonvulsants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial…
CAGR Growth and New Market Options: The Anticonvulsants Market Exploration
The advancing anticonvulsants market showcases steady growth and promising new opportunities as market giants focus on innovation and investment.
What Is The Projected Market Size Of The Global Anticonvulsants Market And Its Growth Rate?
• The anticonvulsants market experienced steady growth in recent years, increasing from $18.85 billion in 2024 to $19.44 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%.
• The market size is projected to continue this…
Anticonvulsants Market Overview, Growth And Forecast 2024-2033
The Business Research Company recently released a comprehensive report on the Global Anticonvulsants Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The anticonvulsants market size has grown…
Anticonvulsants Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Anticonvulsants Market” report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.
The Anticonvulsants market was valued at…